NIH-funded research NIH-funded research

Improving Fracture Healing with Active Plating Technology

Funded at Apex Biomedical Company, LLC · NIH-11405527 · Data updated 2026-11-12

A new plate technology aims to fix broken bones in adults more reliably by providing controlled motion at the fracture to speed healing, especially in those with osteoporosis.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionApex Biomedical Company, LLC
NIH-funded
Lab location1 site (Wilsonville, UNITED STATES)
Project startSeptember 15, 2026
Project endJuly 31, 2029
Funding year2026
Award (this year)$504,235
NIH project number1SB1AR087897-01
Project IDNIH-11405527 on NIH RePORTER

Who could benefit from this research

Could help

Adults 21 years and older with fractures treated using bone plating, especially those with osteoporosis.

Less likely to help

Patients with fractures not suitable for plating or those unlikely to experience improved motion benefits may see no advantage.

What this research studies

This project focuses on a special bone plate that allows a small amount of movement at the fracture to stimulate natural healing while keeping the bones stable. It tests a technology called Active Plating, which suspends screw holes to create elastic movement without losing fixation strength. The goal is faster and more consistent healing compared with standard locked plating, particularly in osteoporotic bone. The work will gather clinical data to support whether this approach improves outcomes for adults with fractures.

Why it matters

Potential benefit: If successful, patients could experience faster healing, fewer complications, and better functional recovery after fractures.

How similar studies have gone: Previous studies suggest that controlled interfragmentary motion can improve fracture healing, but clinical data for active plating is limited and this project aims to strengthen that evidence.

Where this research is happening

  • Apex Biomedical Company, LLC
    Wilsonville, United States
    Active

Researchers

  • Principal investigator: Bottlang, Michael — Apex Biomedical Company, LLC
  • Study coordinator: Bottlang, Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.